01. Doctor Overview

Doctor Overview

Pasi A. Janne博士is a thoracic medical oncologist at the达纳 - 前癌症研究所。He also is a professor at Harvard Medical School and the director of the Lowe Center for Thoracic Oncology, as well as director of the Belfer Center for Applied Cancer Science. Dr. Janne’s mainresearchinterests include the therapeutic relevance of oncogenic alterations in lung cancer. He is affiliated with the cancer genetics and lung cancer programs at Dana-Farber/Harvard Cancer Center.

Dr. Janne has contributed to a number of peer-reviewed journals as an author and co-author. Some of those publications include The New England Journal of Medicine, Oncology, The Journal of the National Cancer Institute, Science, and Cancer Research.

02. Fast Facts

Doctor Fast Facts

主要特色：Thoracic Oncology

其他兴趣和特色：表皮生长因子受体靶向疗法，肺癌，靶向治疗和翻译医学。

Certifications, Awards & Accolades:American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Certification in Medical Oncology, George P. Canellos Award for Excellence in Clinical Investigation and Patient Care, American Society of Clinical Oncology’s Merit Award, Hope Now Award for Lung Cancer Research, Team Science Award, Richard and Hinda Rosenthal Memorial Award, Research Excellence Award

教育与经验：

• 宾夕法尼亚大学医学院医学学位
• 内科居住Brigham and Women’s Hospital, Internal Medicine
• Fellowship in Hematology & Oncology at Dana-Farber/Partners Cancer Care

03. Publications

Publications

分子医学时代肺癌的成像。Academic Radiology。April 2011;18(4): 424-36. doi:10.1016/j.acra.2010.10.020

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-Term follow-up from a pooled analysis of 2 phase 2 studies。癌症。2018年12月。DOI：10.1002/cncr.31891

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma。癌症Research。2002年9月;62（18）：5242-7。

04. Mesothelioma Clinical Trials

Mesothelioma Clinical Trials by Pasi A. Janne, MD, PhD

Janne博士与以下临床试验有关：

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

---

Conditions:Mesothelioma, Mesothelioma, Malignant

最近更新时间：2011年12月23日

Status:完全的

地点:芝加哥，IL。波士顿，马。波士顿，马。

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

---

Conditions:万博专业版间皮瘤，间皮瘤，恶性肿瘤，肺肿瘤

最近更新时间：2013年6月4日

Status:完全的

地点:芝加哥，IL。波士顿，马。